DYN

15.4703.49%
DK

Dirk Kersten

Independent Director

Mr. Dirk Kersten, M.Sc., serves as Managing Partner at Forbion Capital Partners B.V. since January 2025. He joined the firm on October 01, 2018. At Forbion Capital Partners B.V., he also served as General Partner from October 01, 2018 to January 2025. He focuses on Europe and the US. He serves as Director of NorthSea Therapeutics B.V. since December 2021, as Independent Director of Dyne Therapeutics, Inc. since November 2018, as Member of the Supervisory Board of NightBalance B.V. since July 2016, and as Member of the Supervisory Board of Audion Therapeutics BV since September 2015. Mr. Kersten also serves as Director of VMD and serves on the board of Synox Therapeutics. Previously, he was Managing Director of INKEF Netherlands Manager B.V. from May 2014, where he was responsible for all healthcare related investment activities. He served as Partner & Investment Manager of Gilde Healthcare Partners BV, where he led their Boston office and focused on Biotechnology & Nutrition. He also served as Director of Ascendis Pharma A/S, as Director of Symphogen A/S, as Member of the Supervisory Board of ProFibrix, BV, as Director of ViCentra B.V., and as Director of Onward Medical N.V. He manages the Forbion Growth Opportunities Fund and has many years' experience in general fund management, deal making, portfolio management, and exit strategies. He also has many years of training experience as a physicist. He has an M.S. in Physics from University of Groningen from 1993 to 1999.

Positions